StockMarketWire.com - Tristel now anticipates further acceleration in revenue growth and as a consequence has raised its internal expectations both for the current and subsequent financial years.

Pre-tax profit (before share-based payments) for the year ending 30 June 2014 is now expected to be not less than £1.75m (2013: £0.48m adjusted pre-tax profit), the company said in a trading update.

Tristel said in both March and April it was experiencing strong momentum in its underlying business. "This trend is expected to continue through to its June year end and beyond," it said.

Tristel addresses three distinct markets: Human Healthcare, Animal Healthcare and Contamination Control, with three distinctively branded product ranges: Tristel, Anistel and Crystel.










Story provided by StockMarketWire.com